Published in PLoS One on November 26, 2014
Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial (WARCEF) | NCT00041938
Cognitive decline in heart failure. Heart Fail Rev (2016) 0.78
Ischemic aetiology, self-reported frailty, and gender with respect to cognitive impairment in chronic heart failure patients. BMC Cardiovasc Disord (2016) 0.75
Performance of the Automated Neuropsychological Assessment Metrics (ANAM) in detecting cognitive impairment in heart failure patients. Heart Lung (2015) 0.75
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA (2013) 20.79
Fitness effects on the cognitive function of older adults: a meta-analytic study. Psychol Sci (2003) 11.59
Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke (2011) 10.11
The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J (1985) 8.06
Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med (2012) 6.60
The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure. Chest (1996) 5.29
Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med (2002) 4.45
Hypotension and cognitive impairment: Selective association in patients with heart failure. Neurology (2001) 3.33
6-min walk test provides prognostic utility comparable to cardiopulmonary exercise testing in ambulatory outpatients with systolic heart failure. J Am Coll Cardiol (2012) 3.03
Cognitive impairment in older adults with heart failure: prevalence, documentation, and impact on outcomes. Am J Med (2013) 2.56
Cognitive impairment in heart failure: a systematic review of the literature. Eur J Heart Fail (2006) 2.56
Correlates of cognitive impairment among patients with heart failure: results of a multicenter survey. Am J Med (2005) 2.15
Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options. Circulation (2006) 1.67
Cardiac index is associated with brain aging: the Framingham Heart Study. Circulation (2010) 1.57
Relationship between anaemia and cognitive functions in elderly people. Eur J Intern Med (2009) 1.44
Brain injury in autonomic, emotional, and cognitive regulatory areas in patients with heart failure. J Card Fail (2008) 1.41
Psychometric properties of the Folstein Mini-Mental State Examination. Assessment (2005) 1.39
Congestive heart failure and cognitive impairment in an older population. Osservatorio Geriatrico Campano Study Group. J Am Geriatr Soc (1998) 1.35
Cognitive impairment: a key feature of congestive heart failure in the elderly. J Neurol (2003) 1.33
Smoking history and cognitive function in middle age from the Whitehall II study. Arch Intern Med (2008) 1.33
Body mass index and cognitive decline in mild cognitive impairment. Alzheimer Dis Assoc Disord (2010) 1.31
Cardiac dysfunction and cognition in older adults with heart failure. Cogn Behav Neurol (2008) 1.30
Warfarin versus aspirin in patients with reduced cardiac ejection fraction (WARCEF): rationale, objectives, and design. J Card Fail (2006) 1.23
Cognitive impairments in chronic heart failure: a case controlled study. J Card Fail (2008) 1.14
Cardiovascular fitness associated with cognitive performance in heart failure patients enrolled in cardiac rehabilitation. BMC Cardiovasc Disord (2013) 1.01
Cognitive function in patients with decompensated heart failure: the Cognitive Impairment in Heart Failure (CogImpair-HF) study. Eur J Heart Fail (2012) 0.98
Montreal Cognitive Assessment and Mini-Mental Status Examination compared as cognitive screening tools in heart failure. Heart Lung (2011) 0.88
Cognitive change in heart failure: a systematic review. Circ Cardiovasc Qual Outcomes (2013) 0.87
Relationship between cognitive function and 6-minute walking test in older outpatients with chronic heart failure. Aging Clin Exp Res (2010) 0.84
Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med (2012) 6.60
Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study. J Am Coll Cardiol (2014) 3.75
Using the CHA2DS2-VASc score for refining stroke risk stratification in 'low-risk' Asian patients with atrial fibrillation. J Am Coll Cardiol (2014) 2.81
Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation? J Am Coll Cardiol (2015) 1.66
Risk of stroke and intracranial hemorrhage in 9727 Chinese with atrial fibrillation in Hong Kong. Heart Rhythm (2014) 1.61
Age Threshold for Increased Stroke Risk Among Patients With Atrial Fibrillation: A Nationwide Cohort Study From Taiwan. J Am Coll Cardiol (2015) 1.47
Clinical and Echocardiographic Factors Associated With New-Onset Atrial Fibrillation in Heart Failure - Subanalysis of the WARCEF Trial. Circ J (2016) 1.43
The role of monocytes in angiogenesis and atherosclerosis. J Am Coll Cardiol (2013) 1.32
Warfarin versus aspirin in patients with reduced cardiac ejection fraction (WARCEF): rationale, objectives, and design. J Card Fail (2006) 1.23
CHADS2, CHA2DS2-VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention. Thromb Res (2014) 1.05
Acute myocardial infarction in patients with atrial fibrillation with a CHA2DS2-VASc score of 0 or 1: a nationwide cohort study. Heart Rhythm (2014) 0.91
Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry. Am J Med (2014) 0.91
Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure: Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction Trial. Stroke (2016) 0.90
Benefit of warfarin compared with aspirin in patients with heart failure in sinus rhythm: a subgroup analysis of WARCEF, a randomized controlled trial. Circ Heart Fail (2013) 0.89
CHA2 DS2 -VASc score and adverse outcomes in patients with heart failure with reduced ejection fraction and sinus rhythm. Eur J Heart Fail (2016) 0.88
Stroke and bleeding risk co-distribution in real-world patients with atrial fibrillation: the Euro Heart Survey. Am J Med (2014) 0.87
Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis. Heart Rhythm (2014) 0.87
Early cerebral thromboembolic complications after radiofrequency catheter ablation of atrial fibrillation: incidence, characteristics, and risk factors. Heart Rhythm (2014) 0.82
Risk and prediction of dementia in patients with atrial fibrillation--a nationwide population-based cohort study. Int J Cardiol (2015) 0.80
Risk of major bleeding in different indications for new oral anticoagulants: insights from a meta-analysis of approved dosages from 50 randomized trials. Int J Cardiol (2014) 0.80
Performance of bleeding risk-prediction scores in patients with atrial fibrillation undergoing percutaneous coronary intervention. Am J Cardiol (2014) 0.80
Stroke in heart failure in sinus rhythm: the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial. Cerebrovasc Dis (2013) 0.80
Risk of bleeding and stroke with oral anticoagulation and antiplatelet therapy in patients with atrial fibrillation in Taiwan: a nationwide cohort study. PLoS One (2015) 0.79
Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and Heart Failure With Reduced Ejection Fraction Treated With Warfarin or Aspirin. Am J Cardiol (2015) 0.79
Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial substudy. Circ Heart Fail (2015) 0.79
Statins and the risk of dementia in patients with atrial fibrillation: A nationwide population-based cohort study. Int J Cardiol (2015) 0.78
Effects of radiofrequency catheter ablation of atrial fibrillation on soluble P-selectin, von Willebrand factor and IL-6 in the peripheral and cardiac circulation. PLoS One (2014) 0.78
Use of the SAMe-TT2R2 Score to Predict Good Anticoagulation Control with Warfarin in Chinese Patients with Atrial Fibrillation: Relationship to Ischemic Stroke Incidence. PLoS One (2016) 0.78
Recurrent stroke in the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trial. Cerebrovasc Dis (2014) 0.78
Suboptimal oral anticoagulant treatment among Chinese non-valvular atrial fibrillation patients: the Nanchang Atrial Fibrillation Project. Arch Med Sci (2016) 0.77
Atrial fibrillation and heart failure: a bad combination. Am J Cardiol (2014) 0.76
Association of quality of life with anticoagulant control in patients with heart failure: the Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) trial. Int J Cardiol (2014) 0.76
The HAS-BLED Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant Treatment. PLoS One (2015) 0.76
Twice- or once-daily dosing of novel oral anticoagulants for stroke prevention: a fixed-effects meta-analysis with predefined heterogeneity quality criteria. PLoS One (2014) 0.76
Renal Impairment and Prognosis of Patients with Atrial Fibrillation Undergoing Coronary Intervention - The AFCAS Trial. PLoS One (2015) 0.75
Assessing bleeding risk in 4824 Asian patients with atrial fibrillation: The Beijing PLA Hospital Atrial Fibrillation Project. Sci Rep (2016) 0.75
Management of Atrial Fibrillation in Patients With Kidney Disease. J Atr Fibrillation (2014) 0.75
Edoxaban in the evolving scenario of non vitamin K antagonist oral anticoagulants imputed placebo analysis and multiple treatment comparisons. PLoS One (2014) 0.75
Cost-Effectiveness of Apixaban versus Warfarin in Chinese Patients with Non-Valvular Atrial Fibrillation: A Real-Life and Modelling Analyses. PLoS One (2016) 0.75
Determinants and Time Trends for Ischaemic and Haemorrhagic Stroke in a Large Chinese Population. PLoS One (2016) 0.75
Resting Heart Rate and Ischemic Stroke in Patients with Heart Failure. Cerebrovasc Dis (2017) 0.75
Aspirin Does Not Increase Heart Failure Events in Heart Failure Patients: From the WARCEF Trial. JACC Heart Fail (2017) 0.75
Efficacy and safety of triple versus dual antithrombotic therapy in atrial fibrillation and ischemic heart disease: a systematic review and meta-analysis. Oncotarget (2017) 0.75
Bivalirudin use during percutaneous coronary intervention in patients on chronic warfarin therapy. Thromb Res (2014) 0.75
Efficacy and safety of dabigatran, rivaroxaban, and warfarin for stroke prevention in Chinese patients with atrial fibrillation: the Hong Kong Atrial Fibrillation Project. Clin Cardiol (2016) 0.75
Net Clinical Benefit of Dabigatran Over Warfarin in Patients With Atrial Fibrillation Stratified by CHA2DS2-VASc and Time in Therapeutic Range. Can J Cardiol (2016) 0.75
The first prognostic model for stroke and death in patients with systolic heart failure. J Cardiol (2015) 0.75
Predictive accuracy of CHA2DS2-VASc and HAS-BLED scores in patients without atrial fibrillation undergoing percutaneous coronary intervention and discharged on dual antiplatelet therapy. Int J Cardiol (2015) 0.75
Age as a Risk Factor for Stroke in Atrial Fibrillation Patients: Implications in Thromboprophylaxis in the Era of Novel Oral Anticoagulants. J Atr Fibrillation (2013) 0.75